GBI Research, the leading business intelligence provider, has released its latest report, “Pharmaceutical Industry – 2010 Yearbook – Therapeutic Market Landscape, Key Pipeline Drugs,Top Pharma Companies and Key Mergers and Acquisitions” that provides key data, information and analysis of the major trends and issues affecting the Pharmaceutical market. The report provides a comprehensive insight into the history of Pharmaceutical Industry Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions, its uses, efficiency as well as their limitations. The report also provides a detailed analysis of Pharmaceutical Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions in terms of its market size, and the major market drivers and barriers.. The report also looks into Pharmaceutical drug pipeline along with analysis on the pipeline by indication, phase of development and geography of development.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

• The scope of the report includes:
• Detailed overview of Pharmaceutical Industry 2009-2010.
• Annualized market data
• Key market drivers and restraints, challenges and trends shaping the Pharmaceutical market
• Pipeline analysis of the along with segmentation by indication, phase and geography
• Competitive landscape analysis with competitive profiling of leading companies such as
• Analysis of M&A deals from 2009-2010 along with segmentation by value geography and companies

Read More: Therapeutic Area Market

• The report will enhance your decision making capability. It will allow you to
• Develop better strategies pharmaceutical industry
• Develop market-entry and market expansion strategies
• Understand the factors shaping the Pharmaceutical Industry market
• Reinforce R&D pipeline
• Identify the key players best positioned to take the advantage of the opportunities in the pharmaceutical market
• Exploit partnership and acquisition opportunities by identifying the products that could fill the portfolio gaps.

Read More: http://www.researchmoz.com/pharmaceutical-industry-2010-yearbook-therapeutic-market-landscape-key-pipeline-drugs-top-pharma-companies-and-key-mergers-and-acquisitions-report.html

GBI Research’s report, “Medical Polymers Market to 2015” provides in-depth analysis of the global medical polymers market with revenue forecasts up to 2015. It analyses medical polymers market based on product types. Revenue forecasts, which include historical statistics of the market, are provided for all the major regions of the world. The factors that drive and restrain the growth of the medical polymers market are also analyzed in the report. In addition, the research provides market share analysis of the leading medical polymers producers for all the major regions of the world.

Browse Full Report With TOC: Medical Polymers Market

• Medical polymers market globally and for key regions.
• Medical polymers market revenues data from 2005 to 2009 and forecast for six years to 2015.
• Coverage of the various product types.
• Detailed analysis of the key drivers, restraints and challenges for the Medical Polymers Market in all the major regions.
• Information on the competitive landscape with the revenue shares of the leading companies in the major regions of the world.

Read More:Chemicals Market

• Develop business strategies by understanding the trends and developments that are driving the medical polymers market.
• Design and develop your product development, marketing and sales strategies.
• Develop market-entry and market expansion strategies.
• Identify key companies best positioned to take advantage of the emerging market opportunities.
• Benchmark different geographies by the historic and forecasted growth of the global medical polymers market.
• Capitalize by identifying the Medical Polymers Market segments poised for strong growth.
• Identify macro and micro-economic trends shaping and driving the global medical polymers market.

Read More: http://www.researchmoz.com/medical-polymers-market-to-2015-polyvinyl-chloride-pvc-dominating-the-medical-devices-and-packaging-markets-report.html

GBI Research’s new report, “Orthopedic Devices Market in the Emerging Countries (China, India, Brazil) – Presenting New Avenues for Growth and Profitability” provides key data, information and analysis on the orthopedic devices market in China, India and Brazil. The report provides market landscape, competitive landscape and market trends information the orthopedic devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Browse Full Report With TOC: Orthopedic Devices Market

• Key segments covered include orthobiologics, joint reconstruction, spinal surgery, trauma fixation, arthroscopy, orthopedic accessories, orthopedic braces and supports, cranio maxillofacial fixation (CMF), orthopedic reamers, and orthopedic prosthetics.
• Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
• Qualitative analysis of key market trends, market drivers, and restraints by each category within the Orthopedic Devices Market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include DePuy, Stryker Corporation, Zimmer, Synthes, Medtronic, Smith & Nephew, and Biomet.

Read More: Orthopedic Devices Market

• Develop business strategies by understanding the trends and developments that are driving the orthopedic devices market in China, India and Brazil.
• Design and develop your product development, marketing and sales strategies.
• Exploit M&A opportunities by identifying market players with the most innovative pipeline.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
• What’s the next big thing in the Orthopedic Devices Market landscape?
• Identify, understand and capitalize.

Read More: http://www.researchmoz.com/orthopedic-devices-market-in-the-emerging-countries-china-india-brazil-presenting-new-avenues-for-growth-and-profitability-report.html

GBI Research’s medical devices report, “Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers” provides key data, information and analysis on the pharmaceutical analytical services outsourcing in india. The report provides market landscape, competitive landscape and market trends information on the segments within the analytical services market. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, services technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Browse Full Report With TOC: Pharmaceutical Analytical Services Market

• Key geographies covered is India
• Market size and company share data the segments with pharmaceutical anlaytical laboratories market
• Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
• Qualitative analysis of key market trends, market drivers, and restraints by each category within the Pharmaceutical Analytical Services Market.
• The report also covers information on the leading market players, the competitive landscape, services and technologies.

Read More: Pharmaceutical Market

• Develop business strategies by understanding the trends and developments that are driving the Indian Pharmaceutical Analytical Services Market.
• Design and develop your product development, marketing and sales strategies.
• Exploit M&A opportunities by identifying market players with the promising products
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
• What’s the next being thing in the pharmaceutical analytical services market? – Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the Indian pharmaceutical analytical services market and the factors shaping it.

Read More: http://www.researchmoz.com/pharmaceutical-analytical-services-outsourcing-in-india-cost-savings-product-quality-and-shorter-delivery-times-are-key-drivers-report.html

GBI Research’s report, “Oral Drug Delivery Market – Controlled and Sustained Release to be Major Revenue Generators”, provides the key data and analyzes the major challenges and drivers for the Oral Drug Delivery Market. The report also provides in-depth analysis of unmet needs, drivers and barriers that impact the global Oral Drug Delivery Market.

Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets. The report is based on proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts to provide a comprehensive view of the Oral Drug Delivery Market.

Browse Full Report With TOC: Oral Drug Delivery Market

• The scope of this report includes:
• Opportunities and challenges for Oral Drug Delivery Market in the pharmaceuticals industry
• Market revenues and forecasts for Oral Drug Delivery Market in the global pharmaceutical industry from 2009 to 2016.
• The key geographies including the US, Europe, Japan and Emerging Hotspots such as India, Singapore and China.
• Technology trends in Oral Drug Delivery Market. that shape the industry
• Qualitative analysis of the market drivers, barriers, future outlook and challenges for the Oral Drug Delivery Market.
• Analysis of competitive landscape and the leading market players.

Read More: Drug Delivery Market

• The report will enhance your decision making capability. It will allow you to:
• Formulate strategies to increase your company’s growth by understanding the new growth opportunities in Oral Drug Delivery Market.
• Differentiate yourself from competitors and develop new solutions for Oral Drug Delivery Market by understanding the current competitive landscape and how it is evolving to meet the increasing demands
• Draft efficient strategies by understanding best practices, identifying key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
• Make more informed business decisions from the insightful and in-depth analysis of the market for biomanufacturing by analyzing the key technology trends that shape the growth of this market

Read More: http://www.researchmoz.com/oral-drug-delivery-market-controlled-and-sustained-release-to-be-major-revenue-generators-report.html

GBI Research’s new report, “Arthritis Therapeutics Market to 2016 – Biologics Revolutionize Treatment of Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global hepatitis therapeutics market.. Treatment usage patterns, sales, prices and volumes are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Browse Full Report With TOC: Arthritis Therapeutics Market

• The scope of this report includes:
• Annualized market data for the arthritis therapeutics market from 2001 to 2009, forecast forward to 2016.
• Market characterization of the Arthritis Therapeutics Market, including market size, annual cost of therapy and treatment usage patterns.
• Key drivers and barriers that have a significant impact on the market.
• Coverage of pipeline molecules in various phases of drug development. .
• Key M&A activities, licensing agreements that have taken place between 2004 and mid-2010 in the global arthritis therapeutics market.

Read More: Therapeutic Area Market

• The report will enhance your decision making capability. It will allow you to
• Align your product portfolio to the markets with high growth potential.
• Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.
• Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules with more efficiency and better safety.
• Develop key strategic initiatives by understanding the key focus areas of leading companies.
• Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.

Read More: http://www.researchmoz.com/arthritis-therapeutics-market-to-2016-biologics-revolutionize-treatment-of-rheumatoid-arthritis-and-psoriatic-arthritis-report.html

GBI Research’s report, “Musculoskeletal Therapeutics to 2016 – Introduction of Monoclonal Antibodies with First-in-class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis, provides in-depth analysis of unmet needs, drivers and barriers that impact the global musculoskeletal disorders market. The report analyzes the markets for musculoskeletal disorders in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volumes are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Browse Full Report With TOC: Musculoskeletal Disorders Therapeutics Market

• The scope of this report includes:
• Annualized market data for the Musculoskeletal Disorders Therapeutics Market from 2001 to 2009, with forecasts to 2016.
• Data and analysis on the musculoskeletal disorders therapeutics market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.
• Market Data on geographical landscape and therapeutic landscape including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population, treatment seeking population, diagnosis population and prescription population.
• Key drivers and restraints that have created significant impact on the market.
• Competitive landscape of the global musculoskeletal disorders therapeutics market including top companies benchmarking. The key companies studied in this report are Roche/Genentech, Novartis, Amgen, Merck/Schering-Plough, Pfizer/Wyeth, Bristol-Myers Squibb and Eli Lilly, Procter and Gamble, Johnson and Johnson, Abbott Laboratories and Boehringer Ingelheim
• Key M&A activities, Licensing Agreements, that have taken place between 2008 and 2009 in the musculoskeletal disorders therapeutics market.

Read More: Therapeutic Area Market

• The report will enhance your decision making capability. It will allow you to :
• Build effective strategies to launch their pipeline products by identifying potential geographies.
• Exploit in-licensing and out-licensing opportunities by identifying products that might probably fill their portfolio gaps.
• Develop key strategic initiatives by studying the key strategies of top competitors.
• Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
• Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety.

Read More:

http://www.researchmoz.com/musculoskeletal-disorders-therapeutics-to-2016-introduction-of-monoclonal-antibodies-with-first-in-class-mechanism-of-action-to-increase-treatment-options-in-osteoporosis-and-rheumatoid-arthritis-report.html

GBI Research’s report, “Sales Force  Effectiveness in Pharmaceuticals – Cost Pressures Increases Pharmaceutical Companies’ Adoption of New Sales Models and Technologies”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the sales force effectiveness strategies that shape the industry dynamics for the key geographies: the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Further, the report provides competitive benchmarking for the leading companies and analyzes the licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

The scope of this report includes:

• Annualized market data from 2009, forecast forward to 2016.
• Analysis of the leading technology in this space
• Analysis of the R&D models
• Market characterization
• Key drivers and barriers that have a significant impact on the market.
• Competitive benchmarking of leading companies.

Read More: Pharmaceutical Market

• The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
• Develop key strategies to reduce expenditure on sales force and by increasing efficiency
• Develop and understanding of how companies use tools and models in order to improve the sales force productivity
• Make informed decisions with respect to sales force effectiveness
• Identify the leading technology providers for collaborations along with their key capabilities
• Make more informed business decisions from the insightful and in-depth analysis of the sales force effectiveness and the factors shaping it.

Read More:

http://www.researchmoz.com/sales-force-effectiveness-in-pharmaceuticals-cost-pressures-increase-pharmaceutical-companies-adoption-of-new-sales-models-and-technologies-report.html